Syringomyelia-Chiari 2018 International Symposium Organised by the Ann Conroy Trust, in association with Aesculap Academia.


July 17-20, 2018

Birmingham, UK.


Welcome to Birmingham





The symposium is co-organised by The Ann Conroy Trust, in association with Aesculap Academia.


The Ann Conroy Trust is Registered Charity No: 1165808.

We provide Support, Education and Research for patients living with Chiari Malformation, Syringomyelia and associated conditions.

F15 Surgical treatment of syringomyelia associated with adhesive arachnoditis and post-traumatic syringomyelia.


Zuev A, Pedyash N, Epifanov D, Lebedev V, Ghodiwala T.




To analyse the results of the surgical treatment of patients with post-traumatic syringomyelia and to determine the optimal treatment tactics for patients with this pathology.




During the period from 2010 to 2016 the authors treated 44 patients with post-traumatic syringomyelia, out of which 28 patients underwent surgery. The age of the patients ranged from 15 to 58 years. All patients underwent neuroimaging and were examined before and after the operation and were followed-up for a maximum of 54 months.




Patients were divided into 2 groups, 16 patients with uncomplicated spinal cord trauma and 12 patients with complicated spinal cord trauma. In the group of operated patients after uncomplicated spinal cord trauma, there was improvement in condition in 10 patients: 5 patients had no worsening of their condition and 1 patient had progression of syringomyelia. In the group of patients after complicated spinal cord trauma, 4 showed improvement in the condition, another 6 had no worsening and 2 patients had progression of syringomyelia.




The aim of surgery is to eliminate all factors that lead to obstruction of CSF flow. Shunting of a syrinx is a palliative operation with a high risk of recurrence. At the same time, arachnolysis with shunting can improve the results of treatment by reducing the volume of the syrinx, producing a rapid clinical effect. Using the chosen concept of treatment of post-traumatic syringomyelia in our group of patients allowed us to achieve stabilization or improvement in 9 out of 10 patients.